Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Aspen Aerogels Inc (ASPN)

$5.93 0.00 (0.00%)

18:30 EDT ASPN Stock Quote Delayed 20 Minutes

Volume:

Previous Close $5.93

Market Cap 141.62M

PE Ratio -8.12

EPS -0.73

Volume (Avg. Vol.)

Day's Range 5.93 - 5.93

52-Week Range 2.42 - 10.71

Dividend & Yield N/A (N/A)

ASPN Stock Predictions, Articles, and Aspen Aerogels Inc News

From the Web

The Market Timing Secrets No One Talks About - March 30, 2020

From Zacks Investment Research Mar 30, 2020

In the long-run, does consistent market timing really matter to be a successful investor?

Fluor leads industrial gainers; Textron among the losers

From Seeking Alpha Mar 19, 2020

Gainers: Fluor (NYSE:FLR) +53%. Tutor Perini (NYSE:TPC) +46%. RADA Electronic Industries (NASDAQ:RADA) +45%. Select Interior Concepts (NASDAQ:SIC) +42%. Hovnanian Enterprises (NYSE:HOV) +40%.Losers: R

The Market Timing Secrets No One Talks About - March 10, 2020

From Zacks Investment Research Mar 10, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Loss-Making Aspen Aerogels, Inc. (NYSE:ASPN) Expected To Breakeven

From Simply Wall St Mar 8, 2020

Aspen Aerogels, Inc.’s (NYSE:ASPN): Aspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets<div><a class="permalink" href="https://simplywall.st/stocks/us/energy/nyse-aspn/aspen-aerogels/news/loss-making-aspen-aerogels-inc-nyseaspn-expected-to-breakeven/">Read More...</a></div>

Aspen Aerogels (ASPN) Received its Third Buy in a Row

From Smarter Analyst Feb 25, 2020

After B.Riley FBR and Craig-Hallum gave Aspen Aerogels (NYSE: ASPN) a Buy rating last month, the company received another Buy, this time from H.C.

77 Biggest Movers From Yesterday

From Benzinga Feb 25, 2020

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares climbed 166.5% to close at $1.33 on Monday following a licensing agreement the company reached with the Kansas State...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy